Literature DB >> 17641139

Estimation of a preference-based index from a condition-specific measure: the King's Health Questionnaire.

John Brazier1, Carolyn Czoski-Murray, Jennifer Roberts, Martin Brown, Tara Symonds, Con Kelleher.   

Abstract

BACKGROUND: Generic preference-based measures of health may not adequately cover the impact of some conditions. There is therefore increasing interest in developing condition-specific preference-based measures.
OBJECTIVES: The purpose of this study was to estimate a preference-based measure from a condition-specific measure of health for urinary incontinence, the 21-item King's Health Questionnaire, for use in economic evaluation.
METHODS: The King's Health Questionnaire (KHQ) was revised into a 5-dimensional health state classification amenable to valuation using items selected using psychometric evidence. Forty-nine states were valued using standard gamble by a representative sample of patients with urinary incontinence attending UK hospital outpatient clinics. Each respondent was asked to value 9 health states. Models have been estimated for predicting health state valuations for all 1024 states defined by the KHQ classification. The modeling had to cope with the clustering of data by respondent and its skewed distribution.
RESULTS: In total, 110 usable interviews were obtained from 169 patients approached to participate in the study. These responders generated 959 health state valuations. Mean health state values ranged from 0.77 to 0.98. Models were estimated using mean health state values and random effects models of individual-level health state values. These models generated robust estimates of the "main effects," and in general, the results support the ordinality of the KHQ health state classification. There were problems modeling interaction effects, and a number of alternatives were explored.
CONCLUSION: The recommended model for estimating a preference-based measure from the condition-specific KHQ is presented.

Entities:  

Mesh:

Year:  2007        PMID: 17641139     DOI: 10.1177/0272989X07301820

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  44 in total

1.  Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.

Authors:  Mark Parker; Alan Haycox; Jane Graves
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

Review 2.  Evaluation of content on EQ-5D as compared to disease-specific utility measures.

Authors:  Fang-Ju Lin; Louise Longworth; A Simon Pickard
Journal:  Qual Life Res       Date:  2012-06-23       Impact factor: 4.147

3.  Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems (CORE-OM).

Authors:  Ifigeneia Mavranezouli; John E Brazier; Tracey A Young; Michael Barkham
Journal:  Qual Life Res       Date:  2010-10-23       Impact factor: 4.147

Review 4.  A review and critique of studies reporting utility values for schizophrenia-related health states.

Authors:  Ifigeneia Mavranezouli
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Deriving a preference-based measure for cancer using the EORTC QLQ-C30.

Authors:  Donna Rowen; John Brazier; Tracey Young; Sabine Gaugris; Benjamin M Craig; Madeleine T King; Galina Velikova
Journal:  Value Health       Date:  2011 Jul-Aug       Impact factor: 5.725

6.  Economic evaluation in short bowel syndrome (SBS): an algorithm to estimate utility scores for a patient-reported SBS-specific quality of life scale (SBS-QoL™).

Authors:  Andrew Lloyd; Cicely Kerr; Katie Breheny; John Brazier; Aurora Ortiz; Emma Borg
Journal:  Qual Life Res       Date:  2013-09-13       Impact factor: 4.147

7.  Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation.

Authors:  Jonathan W Kowalski; Anne M Rentz; John G Walt; Andrew Lloyd; Jeff Lee; Tracey A Young; Wen-Hung Chen; Neil M Bressler; Paul Lee; John E Brazier; Ron D Hays; Dennis A Revicki
Journal:  Qual Life Res       Date:  2011-08-04       Impact factor: 4.147

Review 8.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 9.  Using QALYs in cancer: a review of the methodological limitations.

Authors:  Martina Garau; Koonal K Shah; Anne R Mason; Qing Wang; Adrian Towse; Michael F Drummond
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

10.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.